Compliance with growth hormone treatment--are they getting it?

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Archives of Disease in Childhood

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/adc.73.3.277-aPMID 8435018PMCID PMC1511296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.

  1988cited by this paper

• A pharmacological profile of somapacitan for the treatment of growth hormone deficiency

  2025cites this paper
• Discomfort towards peers causes therapy-related stress in children and adolescents on daily rhGH therapy

  2025cites this paper
• Relationship between adherence to growth hormone therapy and growth.

  2022cites this paper
• Comparative effectiveness of East Asian traditional medicine for treatment of idiopathic short stature in children: Systematic review and network meta-analysis

  2022cites this paper
• New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain

  2022cites this paper
• Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience

  2021cites this paper
• COMPLIA: A 12-MONTH PROSPECTIVE, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE TREATMENT ADHERENCE AND TREATMENT SATISFACTION IN A GROWTH HORMONE DEFICIENT PAEDIATRIC POPULATION TREATED WITH NUTROPINAQ® A SOMATROPIN ANALOGUE.

  2020cites this paper
• Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS)

  2020cites this paper
• Managing Paediatric Growth Disorders: Integrating Technology Into a Personalised Approach

  2019cites this paper
• Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial

  2019cites this paper
• Long-term adherence to growth hormone therapy in a large health maintenance organization cohort.

  2019cites this paper
• Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)

  2019cites this paper
• Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study

  2019cites this paper
• Adherence, Attitudes and Beliefs of Growth Hormone Deficient Patients - A Questionnaire-based Cohort Study.

  2019cites this paper
• Monitoring of treament adherence with easypodTM in 6 Italian centres: a real-world experience.

  2019cites this paper
• Adherence to somatotropin treatment administered with an electronic device

  2018cites this paper
• Adherence to somatotropin treatment administered with an electronic device.

  2018cites this paper
• Identifying Potentially Modifiable Factors Associated with Treatment Non-Adherence in Paediatric Growth Hormone Deficiency: A Systematic Review

  2018cites this paper
• Sustained Release of Recombinant Human Growth Hormone from Bioresorbable Poly(ester urea) Nanofibers

  2017cites this paper
• Growth hormone delivery devices: current features and potential for enhanced treatment adherence

  2017cites this paper
• Adherence to growth hormone therapy in children and its potential barriers

  2017cites this paper
• Development and Validation of a Pediatric Endocrine Knowledge Assessment Questionnaire: Impact of ac Pediatric Endocrine Knowledge Assessment Questionnaire Intervention Study

  2016cites this paper
• A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey

  2016cites this paper
• Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India

  2016cites this paper
• A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.

  2016cites this paper
• Variability in adherence to rhGH treatment: Socioeconomic causes and effect on children's growth.

  2016cites this paper
• Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein.

  2015cites this paper
• Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring

  2015cites this paper
• An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices

  2015cites this paper
• Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children

  2015cites this paper
• A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

  2014cites this paper
• Adherence to growth hormone therapy: results of a multicenter study.

  2014cites this paper
• User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study

  2013cites this paper
• Comparison of injection dose force, accuracy and precision among three growth hormone injection devices

  2013cites this paper
• Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study

  2013cites this paper
• Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens

  2013cites this paper
• Understanding the Growth Hormone Therapy Adherence Paradigm: A Systematic Review

  2013cites this paper
• Initiating growth hormone therapy for children and adolescents.

  2012cites this paper
• Children and adolescent acceptability of a new device system to administer human growth hormone – a pilot study

  2012cites this paper
• Preterm birth and the endocrine regulation of growth in childhood and adolescence

  2011cites this paper
• Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

  2011cites this paper
• A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children

  2011cites this paper
• Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.

  2011cites this paper
• Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®

  2011cites this paper
• Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth

  2011cites this paper
• Dissolving microneedle patch for transdermal delivery of human growth hormone.

  2011cites this paper
• Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients

  2011cites this paper
• The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.

  2011cites this paper
• Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients.

  2010cites this paper
• Multiple doses of pegylated long‐acting growth hormone are well tolerated in healthy male volunteers and possess a potential once‐weekly treatment profile

  2010cites this paper
• Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.

  2010cites this paper
• Insulin-Like Growth Factor I and Growth Responses during the First Year of Growth Hormone Treatment in KIGS Patients with Idiopathic Growth Hormone Deficiency, Acquired Growth Hormone Deficiency, Turner Syndrome and Born Small for Gestational Age

  2009cites this paper
• Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety.

  2009cites this paper
• Development of a sustained-release recombinant human growth hormone formulation.

  2009cites this paper
• [Nonadherence to GH therapy in children treated with growth hormone].

  2009cites this paper
• Compliance and persistence in pediatric and adult patients receiving growth hormone therapy.

  2008cites this paper
• The impact of fasting and treatment omission on susceptibility to hypoglycaemia in children and adolescents with GH and cortisol insufficiency

  2008cites this paper
• Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.

  2008cites this paper
• Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use

  2007cites this paper
• Understanding and meeting the needs of those using growth hormone injection devices

  2006cites this paper
• Factors Determining Patient Choice of Device for GH Therapy

  2006cites this paper
• Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.

  2004cites this paper
• Optimizing Growth Hormone Efficacy: An Evidence-Based Analysis

  2004cites this paper
• Liquid Growth Hormone: Preservatives and Buffers

  2004cites this paper
• The Role of Somatropin Therapy in Children with Noonan Syndrome

  2003cites this paper
• The management of anemia in pediatric peritoneal dialysis patients

  2003cites this paper
• Are Needle-Free Injections a Useful Alternative for Growth Hormone Therapy in Children? Safety and Pharmacokinetics of Growth Hormone Delivered by a New Needle-Free Injection Device Compared to a Fine Gauge Needle

  2003cites this paper
• Normalization of growth in hypophysectomized mice using hydrodynamic transfer of the human growth hormone gene.

  2003cites this paper
• Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease

  2002cites this paper
• An Open-Label Acceptability Study of Norditropin SimpleXx - A New Liquid Growth Hormone Formulation

  2001cites this paper
• A History of Growth Hormone Injection Devices

  2001cites this paper
• Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution.

  2000cites this paper
• Physician attitudes toward human growth hormone products.

  1999cites this paper
• Norditropin® SimpleXxTM: A Liquid Human Growth Hormone Formulation, a Pen System and an Auto-Insertion Device

  1999cites this paper
• Compliance with Growth Hormone Treatment – Is It a Problem?

  1999cites this paper
• Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment

  1998cites this paper
• Multicentre survey on compliance with growth hormone therapy: what can be improved?

  1998cites this paper
• Growth hormone treatment without a needle using the Preci-Jet 50 transjector

  1997cites this paper
• Non-Compliance bei Therapie mit Wachstumshormon

  1997cites this paper
• Compliance with growth hormone therapy in chronic renal failure and post transplant

  1997cites this paper
• Diagnosis of mycobacterial lymphadenopathy.

  1995cites this paper
• Treatment with growth hormone. What do children know and how do they accept it?

  1995cites this paper
• Nocturnal urinary growth hormone excretion in growth hormone-deficient children on and off growth hormone treatment.

  1995cites this paper
• Overnight oscillations of rectal temperature.

  1995cites this paper
• Automatic needle insertion diminishes pain during growth hormone injection

  1995cites this paper
• Use of Growth Hormone in children with short stature and normal Growth Hormone secretion: a growing problem.

  1994cites this paper
• Improvement of patient convenience in treatment with growth hormone.

  1994cites this paper
• Improvement of Patient Convenience in Treatment with Growth Hormone

  1994cites this paper
• Absorption kinetics of two highly concentrated preparations of growth hormone: 12 IU/ml compared to 56 IU/ml.

  1994cites this paper
• Compliance with growth hormone treatment--are they getting it?

  1993cites this paper
• Patient knowledge and compliance with growth hormone treatment.

  1993cites this paper